Headlines



Reuters
Pharma Equity Group Board Decides To Issue Convertible Loans
TradingView
Pharma Equity Group A/S (PEG) Approves Convertible Loans Up to DKK 4.13M
GlobeNewswire
The Board of Directors' resolution on the issuance of convertible loans
Reuters
PEG: Interpatium Commences Proceedings To Set Aside Arbitral Award
GlobeNewswire
Pharma Equity Group A/S – Challenge to Arbitral Award
Quartr
PEG: Net loss improved to DKK -2.7m, with strengthened IP and ongoing licensing discussions
Quartr
PEG: Net loss narrowed as clinical progress and a key legal win improved financial position, but funding needs persist
GlobeNewswire
Correction to Consolidated Interim Report 1 January – 30 June 2026
Reuters
Pharma Equity Maintains Financial Guidance For 2026
GlobeNewswire
Pharma Equity Group consolidated Interim Report 1 January – 30 June 2026
GlobeNewswire
Pharma Equity Group prevails in international arbitration proceedings and is awarded EUR 10.5 million excluding interest and costs
Reuters
Pharma Equity Group Unit Gets Patent Grant Notification
GlobeNewswire
Pharma Equity Group’s subsidiary Reponex takes key step forward in Inflammatory Bowel Disease with upcoming European patent grant
Reuters
Pharma Equity Group To Borrow Up To About DKK 9.63 Million
GlobeNewswire
Proceedings of the Annual General Meeting of Pharma Equity Group A/S
GlobeNewswire
Notice convening the annual general meeting in Pharma Equity Group A/S
Quartr
PEG: Loss narrowed, clinical milestones advanced, and 2026 guidance targets first revenue
Quartr
PEG: Loss before tax narrowed to DKK -26.4 million amid clinical progress and ongoing funding efforts
GlobeNewswire
Pharma Equity Group A/S - Annual Report 2025
GlobeNewswire
UPDATE OF THE FINANCIAL CALENDAR FOR 2026